[PA4-01] Cost-effectiveness analysis of prevention of development of type 2 diabetesi n borderline diabetic patients

〇Koji Muto¹, Tong Luo², Kyoko Nakazawa³, Shota Saito⁴, Kohei Akazawa² (1.Dept. of Pharmacy, Niigata City General Hospital, 2.Dept. of Medical Infomatics, Niigata University Hospital, 3.Dept. of Pharmacy, Niigata University Hospital, 4.Center for Clinical, Epidemiology and Health Technology Assessment,St. Luke's International University)